Hospital Universitario Infanta Sofía
San Sebastián de los Reyes, Madrid 28702
2 studies enrolling now · 6 studies all time
What they study most
Atrial Fibrillation, DM1, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Myotonic Dystrophy, Myotonic Dystrophy Type 1 (DM1), Obesity, Osteo Arthritis Knee, Overactive Bladder, Overweight, Peritoneal Cancer, Steinert
Studies at this site
- Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1 — Recruiting now
- Computerized Registry of Patients With Venous Thromboembolism (RIETE) — Recruiting now
- A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee — Completed
- A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
- Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) — Completed
- Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed